Anti-angiogenic effects of resveratrol on cerebral angiogenesis

Current Neurovascular Research

Volumn 8, Issue 1, 2011, Pages 14-24

  Chen, Pei Lin ^a   Easton, Alexander S ^a,b,c  

^a Department of Pathology ^*  (Canada)

^b Department of Biochemistry Microbiology and Immunology   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cerebral angiogenesis; Phytochemicals; Resveratrol; Vascular endothelium

Indexed keywords

AURORA A KINASE; BROXURIDINE; CASPASE 3; LACTATE DEHYDROGENASE; MATRIGEL; PROPIDIUM IODIDE; PROTEIN KINASE B; RESVERATROL; TETRAZOLIUM;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; ASSAY; CELL COUNT; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL MIGRATION; CELL TYPE; COMPARATIVE STUDY; CYTOTOXICITY; DOSE RESPONSE; EX VIVO STUDY; EXPLANT; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROVASCULATURE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR RING; WESTERN BLOTTING;

EID: 79951692300     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720211794520233     Document Type: Article

References (57)

1. Harikumar KB, Aggarwal BB. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008;7:1020-35.
2. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
3. Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys 2009;486:95-102.
4. Sofia Vala I, Martins LR, Imaizumi N, et al. Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis. PLoS One 2010;5: e11222.
5. Rouhi P, Lee SL, Cao Z, Hedlund EM, Jensen LD, Cao Y. Pathological angiogenesis facilitates tumor cell dissemination and metastasis. Cell Cycle 2010;9:913-7.
6. Petersen M, Pardali E, van der Horst G, et al. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis. Oncogene 2010;29:1351-61.
7. Young E, Miele L, Tucker KB, Huang M, Wells J, Gu J. SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells. Cancer Biol Ther 2010;10:703-11.
8. Yang G, Rosen DG, Liu G, et al. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res 2010;16:3875-86.
9. Hayashi T, Deguchi K, Nagotani S, et al. Cerebral ischemia and angiogenesis. Curr Neurovasc Res 2006;3:119-29. (Pubitemid 43764788)
10. Penumathsa SV, Maulik N. Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can J Physiol Pharmacol 2009;87:275-86.
11. Nessa A, Latif SA, Siddiqui NI, et al. Angiogenesis-a novel therapeutic approach for ischemic heart disease. Mymensingh Med J. 2009;18:264-72.
12. Kastrup J. Gene therapy and angiogenesis in patients with coronary artery disease. Expert Rev Cardiovasc Ther 2010;8:1127-38.
13. Seevinck PR, Deddens LH, Dijkhuizen RM. Magnetic resonance imaging of brain angiogenesis after stroke. Angiogenesis 2010;13:101-11.
14. Arai K, Jin G, Navaratna D, Lo E. Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J 2009;276:4644-52.
15. Lin MT, Yen ML, Lin CY, Kuo ML. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol 2003;64:1029-36.
16. Cao Y, Fu ZD, Wang F, Liu HY, Han R. Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. J Asian Nat Prod Res 2005;7:205-13. (Pubitemid 40139352)
17. Belleri M, Ribatti D, Savio M, et al. alphavbeta3 Integrindependent antiangiogenic activity of resveratrol stereoisomers. Mol Cancer Ther 2008;7:3761-70.
18. Wang H, Zhou H, Zou Y, et al. Resveratrol modulates angiogenesis through the GSK3beta/beta-catenin/TCF-dependent pathway in human endothelial cells. Biochem Pharmacol 2010;80:1386-95.
19. Pasciu V, Posadino AM, Cossu A, et al. Akt downregulation by flavin oxidase-induced ROS generation mediates dose-dependent endothelial cell damage elicited by natural antioxidants. Toxicol Sci 2010;114:101-12.
20. Srivastava RK, Unterman TG, Shankar S. FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol. Mol Cell Biochem 2010;337:201-12.
21. Hsieh TC, Juan G, Darzynkiewicz Z, Wu JM. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21 (WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res 1999;59:2596-601. (Pubitemid 29269105)
22. Igura K, Ohta T, Kuroda Y, Kaji K. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 2001;171:11-6. (Pubitemid 32727351)
23. Brakenhielm E, Cao R, Cao Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 2001;15:1798-800.
24. Kaga S, Zhan L, Matsumoto M, Maulik N. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol 2005;39:813-22. (Pubitemid 41464418)
25. Khan AA, Dace DS, Ryazanov AG, Kelly J, Apte RS. Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway. Am J Pathol 2010;177(1):481-92.
26. Baron-Menguy C, Bocquet A, Guihot AL, et al. Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic. FASEB J 2007;21:3511-21. (Pubitemid 350075141)
27. Mousa SS, Mousa SA. Effect of resveratrol on angiogenesis and platelet/fibrin-accelerated tumor growth in the chick chorioallantoic membrane model. Nutr Cancer 2005;52:59-65. (Pubitemid 41232650)
28. Hu Y, Sun CY, Huang J, Hong L, Zhang L, Chu ZB. Antimyeloma effects of resveratrol through inhibition of angiogenesis. Chin Med J (Engl) 2007;120:1672-7. (Pubitemid 47603955)
29. Tseng SH, Lin SM, Chen JC, et al. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 2004;10:2190-202.
30. Chen HH, Chien CH, Liu HM. Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct. Stroke 1994;25:1651-7. (Pubitemid 24233974)
31. Holley JE, Newcombe J, Whatmore JL, Gutowski NJ. Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter. Neurosci Lett 2010;470:65-70.
32. Roscoe WA, Welsh ME, Carter DE, Karlik SJ. VEGF and angiogenesis in acute and chronic MOG ((35-55)) peptide induced EAE. J Neuroimmunol 2009;209:6-15.
33. Dong W, Li N, Gao D, Zhen H, Zhang X, Li F. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. J Vasc Surg 2008;48:709-14.
34. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007;2:329-33. (Pubitemid 47040047)
35. Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 1990;63:115-22. (Pubitemid 20234680)
36. Chen PL, Easton AS. Evidence that tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits angiogenesis by inducing vascular endothelial cell apoptosis. Biochem Biophys Res Commun 2010;391:936-41.
37. Berra E, Milanini J, Richard DE, et al. Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol 2000;60:1171-8.
38. Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 2002;90:1243-50. (Pubitemid 34787405)
39. Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-9. (Pubitemid 24142797)
40. Cao Y. Antiangiogenic cancer therapy. Semin Cancer Biol 2004;14:139-45. (Pubitemid 38234756)
41. Eikesdal HP, Kalluri R. Drug resistance associated with antiangiogenesis therapy. Semin Cancer Biol 2009;19:310-7.
42. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006;5:493-506. (Pubitemid 44136961)
43. Kraft TE, Parisotto D, Schempp C, Efferth T. Fighting cancer with red wine? Molecular mechanisms of resveratrol. Crit Rev Food Sci Nutr 2009;49:782-99.
44. Nicholson SK, Tucker GA, Brameld JM. Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc Nutr Soc 2008;67:42-7. (Pubitemid 351185355)
45. Klinge CM, Wickramasinghe NS, Ivanova MM, Dougherty SM. Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J 2008;22:2185-97. (Pubitemid 351948638)
46. Cooke JP, Losordo DW. Nitric oxide and angiogenesis. Circulation 2002;105:2133-5. (Pubitemid 34517153)
47. Schreiner CE, Kumerz M, Gesslbauer J, et al. Resveratrol blocks Akt activation in angiotensin II or EGF-stimulated vascular smooth muscle cells redox-independently. Cardiovasc Res 2010; Epublished ahead of print.
48. Jiang H, Shang X, Wu H, et al. Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells. J Exp Ther Oncol 2009;8:25-33.
49. Parekh P, Motiwale L, Naik N, Rao K. Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells. Exp Toxicol Pathol 2010;63(1-2): 167-73.
50. Wang Y, Romigh T, He X, et al. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and - independent mechanisms in prostate cancer cell lines. Hum Mol Genet 2010;19:4319-29.
51. Yu HP, Yang SC, Lau YT, Hwang T. Role of Akt-dependent upregulation of hemeoxygenase-1 in resveratrol-mediated attenuation of hepatic injury after trauma hemorrhage. Surgery 2010;148:103-09.
52. Penumathsa SV, Thirunavukkarasu M, Zhan L, et al. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J Cell Mol Med 2008;12:2350-61.
53. Zhivotovsky B, Orrenius S. Cell cycle and cell death in disease: past, present and future. J Intern Med 2010;268:395-409.
54. Rashidian J, Iyirhiaro GO, Park DS. Cell cycle machinery and stroke. Biochim Biophys Acta 2007;1772:484-93. (Pubitemid 46400387)
55. Byrnes KR, Faden AI. Role of cell cycle proteins in CNS injury. Neurochem Res 2007;32:1799-807. (Pubitemid 47428847)
56. Singh NP, Hegde VL, Hofseth LJ, Nagarkatti M, Nagarkatti P. Resveratrol (trans-3,5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor. Mol Pharmacol 2007;72:1508-21. (Pubitemid 350146088)
57. Boocock DJ, Patel KR, Faust GE, et al. Quantitation of transresveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J Chromatogr B Anal Technol Biomed Life Sci 2007;848:182-7. (Pubitemid 46464044)